Home Financial Assets Annovis Bio announced that, according to the latest financial assessment, its cash and cash equivalents are expected to be sufficient to maintain normal operations until the third quarter of 2026. – Bitget
Financial Assets

Annovis Bio announced that, according to the latest financial assessment, its cash and cash equivalents are expected to be sufficient to maintain normal operations until the third quarter of 2026. – Bitget

Related Articles

Bangkok Post – B.Grimm issues green bonds

Debentures a first for power arm, Thailand SET-listed B.Grimm Power Plc (BGRIM)...

Samsung, SK Hynix Grow Cash Reserves by Over 117 Trillion Won in 6 Months

Samsung Electronics and SK Hynix have significantly improved their financial soundness as...

Mutual funds eye NSE IPO as the last major capital pool seeks a stake – Moneycontrol.com

Mutual funds eye NSE IPO as the last major capital pool seeks...